| [1] | Greene WC, Peterlin BM (2002) Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat Med 8: 673-680. doi:10.1038/nm0702-673. PubMed: 12091904.
|
| [2] | Malim MH, Emerman M (2008) HIV-1 accessory proteins—ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398. doi:10.1016/j.chom.2008.04.008. PubMed: 18541215.
|
| [3] | Strebel K, Klimkait T, Martin MA (1988) A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241: 1221-1223. doi:10.1126/science.3261888. PubMed: 3261888.
|
| [4] | Cohen EA, Terwilliger EF, Sodroski JG, Haseltine WA (1988) Identification of a protein encoded by the vpu gene of HIV-1. Nature 334: 532-534. doi:10.1038/334532a0. PubMed: 3043230.
|
| [5] | Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K et al. (1996) Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 398: 12-18. doi:10.1016/S0014-5793(96)01146-5. PubMed: 8946945.
|
| [6] | Ewart GD, Mills K, Cox GB, Gage PW (2002) Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu. Eur Biophys J 31: 26-35. doi:10.1007/s002490100177. PubMed: 12046895.
|
| [7] | Ewart GD, Nasr N, Naif H, Cox GB, Cunningham AL et al. (2004) Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages. Antimicrob Agents Chemother 48: 2325-2330. doi:10.1128/AAC.48.6.2325-2330.2004. PubMed: 15155246.
|
| [8] | Maldarelli F, Chen MY, Willey RL, Strebel K (1993) Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol 67: 5056-5061. PubMed: 8331740.
|
| [9] | Wray V, Federau T, Henklein P, Klabunde S, Kunert O et al. (1995) Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. Int J Pept Protein Res 45: 35-43. PubMed: 7775007.
|
| [10] | Federau T, Schubert U, Flossdorf J, Henklein P, Schomburg D et al. (1996) Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int J Pept Protein Res 47: 297-310. PubMed: 8738656.
|
| [11] | Willey RL, Maldarelli F, Martin MA, Strebel K (1992) Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 66: 7193-7200. PubMed: 1433512.
|
| [12] | Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F et al. (1996) The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 70: 809-819. PubMed: 8551619.
|
| [13] | Schubert U, Schneider T, Henklein P, Hoffmann K, Berthold E et al. (1992) Human-immunodeficiency-virus-type-1-enco？dedVpu protein is phosphorylated by casein kinase II. Eur J Biochem 204: 875-883. doi:10.1111/j.1432-1033.1992.tb16707.x. PubMed: 1541298.
|
| [14] | Schubert U, Strebel K (1994) Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 68: 2260-2271. PubMed: 8139011.
|
| [15] | Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430. doi:10.1038/nature06553. PubMed: 18200009.
|
| [16] | Vigan R, Neil SJ (2010) Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J Virol 84: 12958-12970. doi:10.1128/JVI.01699-10. PubMed: 20926557.
|
| [17] | Ewart GD, Sutherland T, Gage PW, Cox GB (1996) The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol 70: 7108-7115. PubMed: 8794357.
|
| [18] | Mehnert T, Routh A, Judge PJ, Lam YH, Fischer D et al. (2008) Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism. Proteins 70: 1488-1497. PubMed: 17910056.
|
| [19] | Hussain A, Das SR, Tanwar C, Jameel S (2007) Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein–a genetic, biochemical and biophysical analysis. Virol J 4: 81. doi:10.1186/1743-422X-4-81. PubMed: 17727710.
|
| [20] | Lu JX, Sharpe S, Ghirlando R, Yau WM, Tycko R (2010) Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci 19: 1877-1896. doi:10.1002/pro.474. PubMed: 20669237.
|
| [21] | Ma C, Marassi FM, Jones DH, Straus SK, Bour S et al. (2002) Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Sci 11: 546-557. PubMed: 11847278.
|
| [22] | Park SH, Mrse AA, Nevzorov AA, Mesleh MF, Oblatt-Montal M et al. (2003) Three-dimensional structure of the channel-forming trans-membrane domain of virus protein "u" (Vpu) from HIV-1. J Mol Biol 333: 409-424. doi:10.1016/j.jmb.2003.08.048. PubMed: 14529626.
|
| [23] | Kukol A, Arkin IT (1999) Vpu transmembrane peptide structure obtained by site-specific fourier transform infrared dichroism and global molecular dynamics searching. Biophys J 77: 1594-1601. doi:10.1016/S0006-3495(99)77007-4. PubMed: 10465770.
|
| [24] | Grice AL, Kerr ID, Sansom MSP (1997) Ion channels formed by HIV-1 Vpu: a modelling and simulation study. FEBS Lett 405: 299-304. doi:10.1016/S0014-5793(97)00198-1. PubMed: 9108308.
|
| [25] | Moore PB, Zhong Q, Husslein T, Klein ML (1998) Simulation of the HIV-1 Vpu transmembrane domain as a pentameric bundle. FEBS Lett 431: 143-148. doi:10.1016/S0014-5793(98)00714-5. PubMed: 9708891.
|
| [26] | Lopez CF, Montal M, Blasie JK, Klein ML, Moore PB (2002) Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1. Biophys J 83: 1259-1267. doi:10.1016/S0006-3495(02)73898-8. PubMed: 12202353.
|
| [27] | Cordes FS, Kukol A, Forrest LR, Arkin IT, Sansom MSP et al. (2001) The structure of the HIV-1 Vpu ion channel: modelling and simulation studies. Biochim Biophys Acta 1512: 29-298. PubMed: 11406106.
|
| [28] | Lemaitre V, Ali R, Kim CG, Watts A, Fischer WB (2004) Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation. FEBS Lett 563: 75-81. doi:10.1016/S0014-5793(04)00251-0. PubMed: 15063726.
|
| [29] | Kim CG, Lemaitre V, Watts A, Fischer WB (2006) Drug-protein interaction with Vpu from HIV-1: proposing binding sites for amiloride and one of its derivatives. Anal Bioanal Chem 386: 2213-2217. doi:10.1007/s00216-006-0832-4. PubMed: 17082882.
|
| [30] | Ulmschneider JP, Ulmschneider MB (2007) Folding simulations of the transmembrane helix of virus protein U in an implicit membrane model. J Chem Theory Comput 3: 2335-2346.
|
| [31] | Patargias G, Martay H, Fischer WB (2009) Reconstructing potentials of mean force from short steered molecular dynamics simulations of Vpu from HIV-1. J Biomol Struct Dyn 27: 1-12. doi:10.1080/07391102.2009.10507291. PubMed: 19492858.
|
| [32] | Kruger J, Fischer WB (2009) Assembly of viral membrane proteins. J Chem Theory Comput 5: 2503-2513.
|
| [33] | Im W, Feig M, Brooks CL III (2003) An implicit membrane generalized Born theory for the study of structure, stability, and interactions of membrane proteins. Biophys J 85: 2900-2918. doi:10.1016/S0006-3495(03)74712-2. PubMed: 14581194.
|
| [34] | Bu L, Im W, Brooks CL III (2007) Membrane assembly of simple helix homo-oligomers studied via molecular dynamics simulations. Biophys J 92: 854-863. doi:10.1529/biophysj.106.095216. PubMed: 17085501.
|
| [35] | Sugita Y, Okamoto Y (1999) Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 314: 141-151. doi:10.1016/S0009-2614(99)01123-9.
|
| [36] | Im W, Lee MS, Brooks CL III (2003) Generalized Born model with a simple smoothing function. J Comput Chem 24: 1691-1702. doi:10.1002/jcc.10321. PubMed: 12964188.
|
| [37] | Zhang Y, Lewis RNAH, McElhaney RN, Ryan RO (1993) Calorimetric and spectroscopic studies of the interaction of Manduca sexta apolipophorin III with zwitterionic, anionic, and nonionic lipids. Biochemistry 32: 3942-3952. doi:10.1021/bi00066a014. PubMed: 8471606.
|
| [38] | Liu F, Lewis RNAH, Hodges RS, McElhaney RN (2004) Effect of variations in the structure of a polyleucine-based alpha-helical transmembrane peptide on its interaction with phosphatidylethanolamine bilayers. Biophys J 87: 2470-2482. doi:10.1529/biophysj.104.046342. PubMed: 15454444.
|
| [39] | Saiz L, Bandyopadhyay S, Klein ML (2004) Effect of the pore region of a transmembrane ion channel on the physical properties of a simple membrane. J Phys Chem B 108: 2608–2613. doi:10.1021/jp0369793.
|
| [40] | Deol SS, Bond PJ, Domene C, Sansom MSP (2004) Lipid-protein interactions of integral membrane proteins: a comparative simulation study. Biophys J 87: 3737-3749. doi:10.1529/biophysj.104.048397. PubMed: 15465855.
|
| [41] | MacKenzie KR, Prestegard JH, Engelman DM (1997) A transmembrane helix dimer: structure and implications. Science 276: 131-133. doi:10.1126/science.276.5309.131. PubMed: 9082985.
|
| [42] | Krüger J, Fischer WB (2010) Structural implications of mutations assessed by molecular dynamics: Vpu1-32 from HIV-1. Eur Biophys J 39: 1069-1077. doi:10.1007/s00249-009-0487-0. PubMed: 19506851.
|
| [43] | Heginbotham L, Abramson T, MacKinnon R (1992) A functional connection between the pores of distantly related ion channels as revealed by mutant K+ channels. Science 258: 1152-1155. doi:10.1126/science.1279807. PubMed: 1279807.
|
| [44] | Heginbotham L, Lu Z, Abramson T, MacKinnon R (1994) Mutations in the K+ channel signature sequence. Biophys J 66: 1061-1067. doi:10.1016/S0006-3495(94)80887-2. PubMed: 8038378.
|
| [45] | Wray V, Kinder R, Federau T, Henklein P, Bechinger B et al. (1999) Solution structure and orientation of the transmembrane anchor domain of the HIV-1-encoded virus protein U by high-resolution and solid-state NMR spectroscopy. Biochemistry 38: 5272-5282. doi:10.1021/bi982755c. PubMed: 10213635.
|
| [46] | Marassi FM, Ma C, Gratkowski H, Straus SK, Strebel K et al. (1999) Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc Natl Acad Sci U_S_A 96: 14336-14341. doi:10.1073/pnas.96.25.14336. PubMed: 10588706.
|
| [47] | Park SH, De Angelis AA, Nevzorov AA, Wu CH, Opella SJ (2006) Three-dimensional structure of the transmembrane domain of Vpu from HIV-1 in aligned phospholipid bicelles. Biophys J 91: 3032-3042. doi:10.1529/biophysj.106.087106. PubMed: 16861273.
|
| [48] | Fischer WB, Forrest LR, Smith GR, Sansom MSP (2000) Transmembrane domains of viral ion channel proteins: a molecular dynamics simulation study. Biopolymers 53: 529-538. doi:10.1002/(SICI)1097-0282(200006)53:7. PubMed: 10766949.
|
| [49] | Brooks BR, Bruccoleri R, Olafson B, States D, Swaminathan S et al. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Phys 4: 187-217.
|
| [50] | Brooks BR, Brooks CL III, MacKerell AD Jr, Nilsson L, Petrella RJ et al. (2009) CHARMM: The biomolecular simulation program. J Comput Chem 30: 1545-1614. doi:10.1002/jcc.21287. PubMed: 19444816.
|
| [51] | MacKerell AD Jr, Bashford D, Bellott M, Dunbrack RL Jr, Evanseck JD et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586–3616. doi:10.1021/jp973084f.
|
| [52] | MacKerell AD Jr, Feig M, Brooks CL III (2004) Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 25: 1400-1415. doi:10.1002/jcc.20065. PubMed: 15185334.
|
| [53] | Schlitter J (1993) Estimation of absolute entropies of macromolecules using the covariance matrix. Chem Phys Lett 215: 617-621. doi:10.1016/0009-2614(93)89366-P.
|
| [54] | Andricioaei I, Karplus M (2001) On the calculation of entropy from covariance matrices of the atomic fluctuations. J Chem Phys 115: 6289-6292. doi:10.1063/1.1401821.
|
| [55] | Nose S (1984) A unified formulation of the constant temperature molecular dynamics methods. J Chem Phys 81: 511-519. doi:10.1063/1.447334.
|
| [56] | Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A 31: 1695-1697. doi:10.1103/PhysRevA.31.1695. PubMed: 9895674.
|
| [57] | Jo S, Kim T, Im W (2007) Automated builder and database of protein/membrane complexes for molecular dynamics simulations. PLOS ONE 2: e880. doi:10.1371/journal.pone.0000880. PubMed: 17849009.
|
| [58] | Jo S, Lim JB, Klauda JB, Im W (2009) CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. Biophys J 97: 50-58. doi:10.1016/j.bpj.2009.04.013. PubMed: 19580743.
|
| [59] | Klauda JB, Venable RM, Freites JA, O'Connor JW, Tobias DJ et al. (2010) Update of the CHARMM all-atom additive force field for lipids: Validation on six lipid types. J Phys Chem B 114: 7830-7843. doi:10.1021/jp101759q. PubMed: 20496934.
|
| [60] | Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935. doi:10.1063/1.445869.
|
| [61] | Essmann U, Perera L, Berkowitz M, Darden T, Lee H et al. (1995) A smooth particle mesh Ewald method. J Chem Phys 103: 8577-8593. doi:10.1063/1.470117.
|
| [62] | Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equation of motions of a system with constraints: Molecular dynamics of n-alkanes. J Comput Chem 23: 327-341.
|
| [63] | Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38. doi:10.1016/0263-7855(96)00018-5. PubMed: 8744570.
|
| [64] | Smart OS, Neduvelil JG, Wang X, Wallace BA, Sansom MSP (1996) HOLE: A program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph 14: 354-360. doi:10.1016/S0263-7855(97)00009-X. PubMed: 9195488.
|
